Receptor binding domain (RBD)

After Pfizer and Moderna, a slew of other candidates could fill gaps in efficacy, production or distribution. AstraZeneca’s COVID vaccine (pictured) is one of the first to receive authorization in the U.K. A number of exciting vaccines are still in the pipeline. Credit: Russell Cheyne Getty Images Six months ago, as the northern hemisphere was still battling…